Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Perry

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
Investigational New Drugs|May 1, 1990
Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B reportQ S Ringenberg, K J Propert, H B Muss, et al.
Lung Cancer (Amsterdam, Netherlands)|March 8, 2000
Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532M C Perry, D C Ihde, J E Herndon, et al.
The New England Journal of Medicine|October 4, 1990
A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancerR O Dillman, S L Seagren, K J Propert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group BA P Chahinian, K J Propert, J H Ware, et al.
The New England Journal of Medicine|April 9, 1987
Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lungM C Perry, W L Eaton, K J Propert, et al.
Anticancer Research|January 1, 1994
Effect of thoracic radiotherapy on mortality in limited small cell lung cancer. A meta-analysis of 13 randomized trials among 2,140 patientsR Arriagada, J P Pignon, D C Ihde, et al.
Lung Cancer (Amsterdam, Netherlands)|January 24, 2012
Differential effect of age on survival in advanced NSCLC in women versus men: analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumabH A Wakelee, S E Dahlberg, J R Brahmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1987
Chemohormonal therapy in advanced carcinoma of the breast: Cancer and Leukemia Group B protocol 8081M C Perry, C G Kardinal, A H Korzun, et al.
The New England Journal of Medicine|December 3, 1992
A meta-analysis of thoracic radiotherapy for small-cell lung cancerJ P Pignon, R Arriagada, D C Ihde, et al.
Lung Cancer (Amsterdam, Netherlands)|September 1, 1996
A phase I/II trial of etoposide and cisplatin in extensive small cell lung cancer: a cancer and leukemia group B studyE P Mitchell, M C Perry, S D Luikart, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Investigational New Drugs|May 1, 1990
Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B reportQ S Ringenberg, K J Propert, H B Muss, et al.
Lung Cancer (Amsterdam, Netherlands)|March 8, 2000
Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532M C Perry, D C Ihde, J E Herndon, et al.
The New England Journal of Medicine|October 4, 1990
A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancerR O Dillman, S L Seagren, K J Propert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group BA P Chahinian, K J Propert, J H Ware, et al.
The New England Journal of Medicine|April 9, 1987
Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lungM C Perry, W L Eaton, K J Propert, et al.
Anticancer Research|January 1, 1994
Effect of thoracic radiotherapy on mortality in limited small cell lung cancer. A meta-analysis of 13 randomized trials among 2,140 patientsR Arriagada, J P Pignon, D C Ihde, et al.
Lung Cancer (Amsterdam, Netherlands)|January 24, 2012
Differential effect of age on survival in advanced NSCLC in women versus men: analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumabH A Wakelee, S E Dahlberg, J R Brahmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1987
Chemohormonal therapy in advanced carcinoma of the breast: Cancer and Leukemia Group B protocol 8081M C Perry, C G Kardinal, A H Korzun, et al.
The New England Journal of Medicine|December 3, 1992
A meta-analysis of thoracic radiotherapy for small-cell lung cancerJ P Pignon, R Arriagada, D C Ihde, et al.
Lung Cancer (Amsterdam, Netherlands)|September 1, 1996
A phase I/II trial of etoposide and cisplatin in extensive small cell lung cancer: a cancer and leukemia group B studyE P Mitchell, M C Perry, S D Luikart, et al.
Pageof 16